Seeking Alpha

Curis, Inc. (CRIS)

From other sites
CRIS vs. ETF Alternatives
Company Description
Curis, Inc., is a drug discovery and development company. The Company is engaged in the development of its proprietary targeted cancer drug candidates, including CUDC-907, HDAC and phosphatidylinositol-3-kinase, or PI3K.
Sector: Healthcare
Industry: Biotechnology
Country: United States